This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
RETRACTION: Fibronectin Enhances Tumor Metastasis Through B7‐H3 in Clear Cell Renal Cell Carcinoma
TL;DR
A paper about fibronectin's role in kidney cancer metastasis has been retracted due to image duplication issues.
Contribution
The paper originally claimed fibronectin promotes metastasis via B7-H3 in clear cell renal cell carcinoma.
Findings
The paper was retracted due to duplicated figures.
The authors and editors agreed the data's integrity was compromised.
The conclusions of the study are no longer considered reliable.
Abstract
RETRACTION: J. Xie, M. Sun, D. Zhang, C. Chen, S. Lin, and G. Zhang,“Fibronectin Enhances Tumor Metastasis Through B7‐H3 in Clear Cell Renal Cell Carcinoma,” FEBS Open Bio 11, no. 11 (2021): 2977‐2987, https://doi.org/10.1002/2211‐5463.13280. The above article, published online on 25 August 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor‐in‐Chief, Miguel De la Rosa; the Federation of European Biochemical Societies; and John Wiley & Sons Ltd. UK. The retraction has been agreed due to the discovery of duplications in Figures 2C and 5A. The authors originally reported these irregularities to the journal and offered corrected figures to replace the published figures. Upon the journal's analysis of the original image data, additional irregularities were found, including other image duplications with…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis · Renal cell carcinoma treatment · Nanoplatforms for cancer theranostics
RETRACTION: J. Xie, M. Sun, D. Zhang, C. Chen, S. Lin, and G. Zhang,“Fibronectin Enhances Tumor Metastasis Through B7‐H3 in Clear Cell Renal Cell Carcinoma,” FEBS Open Bio 11, no. 11 (2021): 2977‐2987, https://doi.org/10.1002/2211‐5463.13280.
The above article, published online on 25 August 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor‐in‐Chief, Miguel De la Rosa; the Federation of European Biochemical Societies; and John Wiley & Sons Ltd. UK. The retraction has been agreed due to the discovery of duplications in Figures 2C and 5A. The authors originally reported these irregularities to the journal and offered corrected figures to replace the published figures. Upon the journal's analysis of the original image data, additional irregularities were found, including other image duplications with repositioning. Given the extent of the identified issues, the editors have lost confidence in the data presented and consider the conclusions of this manuscript substantially compromised. As a result, the Editor‐in‐Chief, FEBS Press, and John Wiley and Sons Ltd. have determined that a retraction is necessary. The authors agree with this decision.